Hypothesis: NAD+ Directly Regulates Translation Initiation Through eIF4E-BP to Enforce a Metabolic Thrift State

We propose that falling NAD+ levels act as a direct signal to the translation machinery, promoting a thrift state that limits anabolic growth. This response is protective early in life by curbing unchecked proliferation and reducing replication‑associated DNA damage. With advancing age, however, the same mechanism becomes maladaptive because sustained suppression of protein synthesis erodes mitochondrial biogenesis, repair capacity, and stress‑resilient proteostasis, feeding into the phenotypes described in the NAD+ depletion literature.1

Mechanistic Basis

Recent structural work shows that the N‑terminal domain of eukaryotic initiation factor 4E‑binding protein (4E‑BP) harbors a conserved Rossmann‑fold motif capable of binding nicotinamide adenine dinucleotide.3 We hypothesize that NAD+ binding stabilizes the hypophosphorylated, active form of 4E‑BP, which sequesters eIF4E and inhibits cap‑dependent translation. When NAD+ declines, less ligand is available, shifting the equilibrium toward the phosphorylated, inactive state of 4E‑BP and thereby releasing translational repression. Conversely, high NAD+ favors the active repressor form, lowering global protein synthesis.

This model flips the usual view: rather than NAD+ loss merely removing a cofactor for sirtuins, it directly alters a translational checkpoint that couples cellular energy status to growth‑promoting programs. The thrift state would reduce ribosome load, lower ATP consumption, and decrease production of replication‑associated reactive oxygen species, affording a temporary safeguard against oncogenic transformation and proteotoxic stress.

Predictions

1. In vitro – Recombinant 4E‑BP will show increased NAD+‑dependent binding in fluorescence‑polarization assays, with a Kd in the low‑micromolar range matching physiological NAD+ fluctuations.
2. In cells – Acute NAD+ depletion (using FK866 to inhibit NAMPT) will increase polysome association of reporters lacking a functional 4E‑BP binding site, while wild‑type reporters remain translationally repressed; rescue with NAD+ precursors will restore repression only when wild‑type 4E‑BP is present.
3. In vivo – Mice expressing a NAD+‑binding‑deficient 4E‑BP mutant (point mutations in the Rossmann fold) will exhibit higher basal protein synthesis rates in liver and muscle, reduced lifespan, and accelerated onset of age‑related phenotypes despite normal NAD+ levels.
4. Genetic interaction – Combining the 4E‑BP mutant with a heterozygous loss of mTORC1 (to lower translational drive) should normalize lifespan, indicating that the deleterious effects stem from unchecked translation when NAD+ sensing is broken.
5. Translational profiling – Ribosome‑sequencing from young versus old wild‑type mice will reveal a global shift toward translation of mRNAs with upstream open reading frames or internal ribosome entry sites, characteristic of a stress‑adapted translatome, a shift blunted in the 4E‑BP mutant.

Experimental Approach

• Biochemical: Express and purify WT and mutant 4E‑BP; measure NAD+ binding via isothermal titration calorimetry and thermal shift assays.
• Cellular: Use CRISPR‑edited HEK293 lines expressing FLAG‑tagged WT or mutant 4E‑BP; treat with NAD+ modulators (NR, FK866) and perform polysome profiling followed by qPCR for housekeeping versus stress‑response transcripts.
• Animal: Generate knock‑in mice bearing the NAD+‑binding‑deficient 4E‑BP allele; monitor NAD+ levels, protein synthesis rates (SUnSET assay), mitochondrial respiration, frailty index, and survival over 30 months.
• Rescue: Administer NR or NAMPT‑overexpressing AAV to aged mutant mice to test whether boosting NAD+ fails to repress translation in the absence of the sensor.

Falsifiability

If NAD+ does not directly regulate 4E‑BP, then mutations disrupting the putative binding site will not alter translation or lifespan despite normal NAD+ flux, and NAD+ supplementation will still restore sirtuin activity and improve healthspan without affecting global protein synthesis. Conversely, demonstrating that the mutant uncouples NAD+ levels from translational control and shortens healthspan would support the hypothesis and reposition NAD+ decline as an active, sensor‑driven program rather than a passive metabolic breakdown.